MRI and CT planning for esophagus or stomach-junction cancer treatment
Part of Cancer, Digestive system clinical trials.
This study checks whether MRI and CT scans can better measure how esophageal or stomach-junction tumors respond during chemoradiotherapy and help doctors map the exact treatment area. It may help improve targeting while you receive standard treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed cancer type: squamous cell cancer or adenocarcinoma in the esophagus or stomach junction
- Your tumor is not fully removable right now (unresectable) or might be removed later (potentially resectable)
- Cancer spread is limited: no distant metastasis except possibly to nearby supraclavicular lymph nodes
- You are age 18 or older and can sign consent
- You have not had prior chemotherapy or radiation to the chest area
- Your organs/blood tests are in acceptable ranges (including white blood cells, platelets, and liver/kidney blood tests)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests a cancer treatment plan that combines chemotherapy and radiation for people with esophageal or esophagus-stomach junction cancer. It aims to see whether this approach works better than standard care for cancers at stages I to IVA.
This study tests whether a special imaging scan (functional imaging) can identify which esophageal cancers respond best to radiation. If you have stage II–IVA esophageal cancer and meet the health criteria, joining may help personalize your treatment.
This trial studies how to best target radiation for people with advanced esophageal cancer who are also getting immunotherapy. It aims to improve treatment planning to help patients live longer with fewer side effects.
This Phase 1 study uses specialized imaging (including MRI) to better “see” low-oxygen areas in esophageal cancer and help guide individualized radiation treatment. It aims to improve how radiation is planned and delivered while checking safety.
This study looks at using a standardized MRI scan (a detailed imaging test) and structured reporting to better evaluate esophageal squamous cell carcinoma before surgery. The goal is to improve how doctors plan and assess treatment, potentially leading to more precise surgery and better outcomes for patients.
This study tests whether a combined PET-MRI scan can be done safely and used to help plan treatment for people with locally advanced esophageal cancer. It may improve how doctors map the cancer and plan radiation therapy, but it is mainly a feasibility (testing-setup) study.
Hear when a new Esophagus Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.